Care of Patients with Diabetic Retinopathy Diabetic retinopathy is a leading cause of both
moderate and severe vision loss worldwide. Over the past decade, advances in technology …

The prevalence of diabetes is rapidly increasing, and it is now the leading cause of
blindness worldwide. Although early detection of diabetic retinopathy is key to preventing …

Background: Diabetic retinopathy is a leading cause of visual impairment in working-age
adults worldwide. Duration of diabetes is a major risk factor associated with the development …

Purpose To assess change in retinal nonperfusion (NP) after anti–vascular endothelial
growth factor (VEGF) therapy for diabetic macular edema (DME) using 2 different imaging …

Purpose To compare anatomic and functional outcomes in eyes with proliferative diabetic
retinopathy (PDR) that were lost to follow-up (LTFU) for more than 6 months after treatment …

Concerning costs, high rates of noncompliance in the diabetic population and significant
rates of subsequent treatments with initial PRP and anti-VEGF, early vitrectomy for diabetic …

Purpose: To compare the changes in retinal perfusion on ultra–wide-field fluorescein
angiography with the changes in diabetic retinopathy lesions observed on ultra–wide-field …

Background: Diabetic retinopathy (DR) is the leading cause of blindness in the working-age
population. The purpose of this review is to gather the existing literature regarding the use of …

Purpose To analyze and compare loss to follow-up (LTFU) rates between patients with
diabetic retinopathy (DR) and those with neovascular age-related macular degeneration …

Purpose To illustrate that patients with diabetic retinopathy who are treated exclusively with
anti–vascular endothelial growth factor (VEGF) therapy and have an interruption in treatment …